The Nintendo Switch 2 is flying off shelves, but issues with the console's USB-C ports have raised concerns about Nintendo's ...

For years, APIs have powered everything from SaaS dashboards to mobile apps. Now, a new contender—Model Context Protocol, or ...

According to The Financial Times, JPMorgan has emailed staffers already working at the new Manhattan building to notify them that biometric access is “required” instead of voluntary. Biometric ...

VCN-01 expanded mPDAC data from VIRAGE Phase 2b trial to be presented at ESMO 2025 - - SYN-004 Interim blinded safety and ...

Everest Medicines (HKEX 1952.HK, 'Everest', or the 'Company'), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative ...

Thailand's cybersecurity systems remain vulnerable to a high number of attacks, according to cybersecurity firms.

China NMPA approves Everest Medicines’s IND application for tumour-associated antigen cancer vaccine EVM14: Shanghai, China Tuesday, October 14, 2025, 14:00 Hrs [IST] Everest Me ...

Cisco Systems Inc. today announced its 8223 routing system, powered by its new Silicon One P200 chip — a new network system ...

Canadian biotech Pascal Biosciences Inc will start an early stage study of a cannabis-based cancer therapy in partnership with SoRSE Technology Corp, the companies told Reuters on Monday.

As agentic artificial intelligence becomes widespread, a new cyberattack vector—vibe hacking—is emerging, raising alarms ...

When a good die fails test and gets scrapped, often no one notices, because false failures look identical to real ones. Yet across the industry, these phantom defects are quietly eroding yield, ...

Approval based on pivotal Phase 3 C-POST trial showing Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to ...